You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 19, October 25, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching Hospital

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with great interest the study by van der Klauw et al1 of drug-associated agranulocytosis in a Dutch hospital. We agree with their conclusions (the highest risks of drug-induced agranulocytosis occur with thyroid inhibitors, the combination drug sulfamethoxazole-trimethoprim, sulfasalazine, clomipramine hydrochloride, and dipyrone combined with analgesics) and want to give some data from our own experience.2

Fifty-eight episodes of drug-induced agranulocytosis (neutrophil count, <0.5x109/L; all patients fulfilled the criteria of Benichou and Solal-Celignoy3) were treated at Strasbourg Teaching Hospital, Strasbourg, France, between January 1985 and January 1997. The mean age of the patients was 65.7 years, and the female-male ratio was 1:4. During hospitalization, all patients had at least 1 of the following manifestations: isolated fever and chills (17/58 [31%]), sore throat (13/58 [22.4% ]), septicemia (12/58 [21%]), pneumonia (11/58 [14%]), or other localized infections (7/58 [11.6%]). The mean neutrophil count was 0.09x109. . . [Full Text of this Article]

Andrès Emmanuel, MD; Frédéric Maloisel, MD
Strasbourg, France



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A Population-Based Case-Cohort Study of Drug-Associated Agranulocytosis
Melanie M. van der Klauw, Robert Goudsmit, M. Ruud Halie, Mars B. van't Veer, Ron M. C. Herings, J. H. Paul Wilson, and Bruno H. Ch. Stricker
Arch Intern Med. 1999;159(4):369-374.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pseudomonas aeruginosa Ecthyma Gangrenosum and Facial Cellulitis Complicating Carbimazole-Induced Agranulocytosis
del Giudice et al.
Arch Dermatol 2006;142:1663-1664.
FULL TEXT  

Antibiotic-Induced Agranulocytosis: A Monocentric Study of 21 Cases
Andres and Maloisel
Arch Intern Med 2001;161:2619-2619.
FULL TEXT  

Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis
Andres et al.
QJM 2001;94:423-428.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.